Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07227376 · ClinicalTrials.gov registry record

Data Collection Using Eko Digital Devices in a Clinical Setting

A clinical trial of Lung Diseases, sponsored by Eko Devices.

Recruiting
Registry status
250
Enrollment target
2
Study locations

NCT07227376: Recruiting study of Lung Diseases, sponsored by Eko Devices.

NCT07227376 is a study of Lung Diseases that is actively recruiting participants, run by Eko Devices. The registered enrollment target is 250 participants, below the 732-participant average among 31 other Lung Diseases trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07227376, a study of Lung Diseases, is actively recruiting participants, sponsored by Eko Devices.

RECRUITING
Registry status
250 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research is to prospectively train and validate an artificial intelligence machine learning (ML) algorithm to detect the presence of adventitious lung sounds in adults. Clinicians will use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings to collect normal and abnormal lung sounds, as part of standard of care clinical practice, which will then be used to explore an ML algorithm for classifiers for wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough, as well as determine any correspondences between the type and/or location of adventitious lung sounds and the type of pulmonary conditions as reported by clinicians.

Primary Outcome

The primary objective of this study is to collect normal and abnormal lung sounds of up to 750 patients per study site, by having clinicians use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings, as part of standard of care clinical practice which will then be used to explore an ML algorithm for classifiers for wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough, as well as determine any correspondences between the type and/or location of adventitious lun

Conditions Studied

Interventions

  • DEVICE Eko digital stethoscopes

Study Locations (2)

Florida

  • Nemours Children's Health - Jacksonville

Pennsylvania

  • Jefferson Einstein Philadelphia Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-09-14
Est. Completion 2026-07-01
Eko Devices

16 total trials

What NCT07227376 shows while recruiting

NCT07227376 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 732-participant average among 31 other Lung Diseases trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 1 intervention - of which Eko digital stethoscopes is the first listed.

NCT07227376 reports a single indexed study location in Florida, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07227376 about?

NCT07227376 is a clinical study titled "Data Collection Using Eko Digital Devices in a Clinical Setting". The purpose of this research is to prospectively train and validate an artificial intelligence machine learning (ML) algorithm to detect the presence of adventitious lung sounds in adults. Clinicians will use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings to collect normal and ...

What is the current status of trial NCT07227376?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-09-14. Estimated completion is 2026-07-01.

What conditions does trial NCT07227376 study?

This clinical trial studies the following conditions: Lung Diseases.

What interventions are being tested in trial NCT07227376?

The interventions under investigation include: Eko digital stethoscopes (DEVICE).

Who is sponsoring clinical trial NCT07227376?

This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07227376 being conducted?

This trial has 2 study locations across Florida, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07227376's enrollment target sits among peer trials

250 17th of 31 higher than 15 of 31 other Lung Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07227376, the US trial registry maintained by the National Library of Medicine. NCT07227376 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.